Results 171 to 180 of about 6,658 (202)

Rucaparib

Reactions Weekly, 2018
openaire   +1 more source

Synthesis of Rucaparib

Synfacts, 2020
openaire   +1 more source

Niraparib/olaparib/rucaparib

Reactions Weekly, 2022
openaire   +1 more source

Rucaparib Cocrystal: Improved Solubility and Bioavailability Over Camsylate

International Journal of Pharmaceutics, 2023
Bingqing Zhu, Xuefeng Mei, Wenjuan Dai
exaly  

Rucaparib

2020
openaire   +1 more source

Evaluation of Absorption, Distribution, Metabolism, and Excretion of [14C]-Rucaparib, a Poly(ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced Solid Tumors

Investigational New Drugs, 2020
Mingxiang Liao, Jim J Xiao
exaly  

Pharmacokinetics and Safety of Rucaparib in Patients With Advanced Solid Tumors and Hepatic Impairment

Cancer Chemotherapy and Pharmacology, 2021
Monika Tomaszewska, Yvette Drew, Rafal Dziadziuszko   +2 more
exaly  

Method of the synthesis of selenium homolog of rucaparib

Chemistry of Heterocyclic Compounds, 2023
Sindija Lapcinska, Pavel Arsenyan
openaire   +1 more source

Rucaparib Maintenance Treatment for Recurrent Ovarian Carcinoma After Response to Platinum Therapy (ARIEL3): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Lancet, The, 2017
Giovanni Scambia, Andrew Dean, Jesus Garcia-donas   +2 more
exaly  

The Effect of Age on Efficacy, Safety and Patient-Centered Outcomes With Rucaparib: A Post Hoc Exploratory Analysis of ARIEL3, a Phase 3, Randomized, Maintenance Study in Patients With Recurrent Ovarian Carcinoma

Gynecologic Oncology, 2020
Juliette Meunier, Andrew Dean, Jesus Garcia-donas   +2 more
exaly